Working Group 5

Regulatory, education, technology transfer, trainings and dissemination

Objectives and Activities

INFOGUT aims to become a think tank and a business incubator for technology related to reference in vitro gut models and related protocols. This requires a strict coordination of all channels of the Action WGs for permanent information flow throughout scientific community and between academia and industries also taking into consideration the guidance of ethical and regulatory bodies which will be involved. Moreover, the development capacity of INFOGUT lies in the opportunity for academic laboratories and industrial partners to develop an educational program together with a dissemination strategy.

Working group leaders

Pilar Acedo

WG5 Leader
University College London, Royal Free Hospital

Laure-Alix Clerbaux

WG5 Co-Leader
UCLouvain, Brussels

Tasks

Task 5.1.

Support to translational studies of food/feed, ingredients, supplements, drug therapies

Task 5.2.

Educational tools (YRIs, consumers, academics, students)

Task 5.3.

Transfer to industries and training to professionals.

Deliverables

D5.1

Atlas of support to translational studies to be implemented in the website - month 24

D5.2

Plan of Training Event for Academics, YRIs and Professionals d-month 18

D5.3

Final report of dissemination activities for the General Public and Scientific Community - month 48

Working group meetings

COST

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation. (www.cost.eu)

Cost EU
COST Action CA23110

Scientific literature is shedding light on the centrality of GI for human health and wellbeing. Indeed, the physiologic effects of nutrients, bioactives and even toxic compounds (including foodborne pathogens) are mediated by their absorption rate in the intestine and by their interaction with gut microbiota and its host ecosystem. Testing food, feed, supplements or drugs in clinical studies gives rise to ethical issues, and the transferability of animal data across species is often problematic because of differences in physiology, metabolism and chemical susceptibilities.

Discover

MoU
062/22

CSO Approval Date
27/05/2022

Start Date
06/10/2022

End Date
05/10/2026

2025 | Cost Action CA23110 | All Right Reserved  | Design by Onno Media